Low dose Naltrexone for induction of remission in inflammatory bowel disease patients

BACKGROUND: Around 30% of patients with inflammatory bowel disease (IBD) are refractory to current IBD drugs or relapse over time. Novel treatments are called for, and low dose Naltrexone (LDN) may provide a safe, easily accessible alternative treatment option for these patients. We investigated the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Transl Med
Asıl Yazarlar: Lie, Mitchell R. K. L., van der Giessen, Janine, Fuhler, Gwenny M., de Lima, Alison, Peppelenbosch, Maikel P., van der Ent, Cokkie, van der Woude, C. Janneke
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2018
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5845217/
https://ncbi.nlm.nih.gov/pubmed/29523156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-018-1427-5
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller